Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Alerg Mex ; 43 Spec No: 6-7, 1996.
Article in Spanish | MEDLINE | ID: mdl-8898564

ABSTRACT

No ancillary or laboratory study can replace the medical history and physical examination, in the diagnosis of allergic diseases. It is mandatory to know the wide diversity of clinical manifestations to make an accurate diagnosis and select its best treatment.


Subject(s)
Rhinitis/diagnosis , Sinusitis/diagnosis , Chronic Disease , Humans , Medical History Taking , Nose/pathology , Physical Examination , Rhinitis/pathology , Rhinitis, Allergic, Perennial/diagnosis , Rhinitis, Allergic, Perennial/pathology , Sinusitis/immunology , Sinusitis/pathology
3.
Rev Alerg Mex ; 42(2): 28-31, 1995.
Article in Spanish | MEDLINE | ID: mdl-7542992

ABSTRACT

We studied 104 medical student from the UANL with symptoms of Perennial Allergic Rhinitis, including only 30 patients for this study; seven patients with Loratadine 10 mg, eight with Loratadine 20 mg, and 15 with Terfenadine 120 mg/day/21 days, 20 mg of Loratadine and 120 mg of Terfenadine demonstrated significant decrease of the symptoms (P > 0.005). Two patients had collateral effects with Terfenadine, but Terfenadine were more effective than the Loratadine in the reduction of the skin reactivity.


Subject(s)
Histamine Release/drug effects , Intradermal Tests , Loratadine/therapeutic use , Rhinitis, Allergic, Perennial/drug therapy , Terfenadine/therapeutic use , Adolescent , Adult , Depression, Chemical , Female , Humans , Loratadine/adverse effects , Loratadine/pharmacology , Male , Safety , Terfenadine/adverse effects , Terfenadine/pharmacology
4.
Rev Alerg Mex ; 41(6): 143-6, 1994.
Article in Spanish | MEDLINE | ID: mdl-7834324

ABSTRACT

We studied 104 medical student from the UANL, with symptoms of perenneal allergic rhinitis, including only 30 patients for this study; seven patients with loratadin 10 mg, eight with loratadine 20 mg and 15 with terfenadine 120 mg/day/21 days, 20 mg of loratadine and 120 mg of terfenadine demonstrated significant decrease of the symptoms (P). Two patients had collateral effects with terfenadine, but terfenadine were more effective than the loratadine in the reduction of the skin reactivity.


Subject(s)
Loratadine/therapeutic use , Rhinitis, Allergic, Perennial/drug therapy , Terfenadine/therapeutic use , Adolescent , Adult , Drug Administration Schedule , Humans , Rhinitis, Allergic, Perennial/complications , Skin/drug effects , Skin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...